$369 Million is the total value of TRV GP III, LLC's 7 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
RVMD | REVOLUTION MEDICINES, INC. | $140,918,000 | +1.4% | 5,524,031 | 0.0% | 38.24% | +9.9% | |
FULC | FULCRUM THERAPEUTICS, INC. | $93,706,000 | +33.7% | 3,962,202 | 0.0% | 25.43% | +45.0% | |
VYGR | VOYAGER THERAPEUTICS, INC. | $48,701,000 | +181.2% | 6,391,176 | 0.0% | 13.22% | +204.9% | |
PLRX | PLIANT THERAPEUTICS, INC. | $40,933,000 | -48.1% | 5,839,160 | 0.0% | 11.11% | -43.7% | |
NRIX | Sell | NURIX THERAPEUTICS, INC. | $26,935,000 | -61.6% | 1,922,549 | -20.6% | 7.31% | -58.4% |
DBTX | DECIBEL THERAPEUTICS, INC. | $9,545,000 | -34.6% | 3,139,685 | 0.0% | 2.59% | -29.1% | |
JNCE | JOUNCE THERAPEUTICS, INC. | $7,800,000 | -18.7% | 1,148,780 | 0.0% | 2.12% | -11.8% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Mark Levin #1
- Kevin P. Starr #2
- Robert I. Tepper #3
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-10
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VOYAGER THERAPEUTICS, INC. | 22 | Q1 2023 | 74.0% |
JOUNCE THERAPEUTICS, INC. | 20 | Q3 2022 | 24.5% |
PLIANT THERAPEUTICS, INC. | 14 | Q3 2023 | 100.0% |
FULCRUM THERAPEUTICS, INC. | 14 | Q4 2022 | 43.8% |
REVOLUTION MEDICINES, INC. | 12 | Q4 2022 | 53.8% |
DECIBEL THERAPEUTICS, INC. | 10 | Q2 2023 | 66.3% |
NEON THERAPEUTICS, INC. | 8 | Q1 2020 | 41.1% |
NURIX THERAPEUTICS, INC. | 8 | Q2 2022 | 17.7% |
RELAY THERAPEUTICS, INC. | 2 | Q4 2020 | 37.7% |
MYOKARDIA, INC. | 2 | Q1 2018 | 22.1% |
View TRV GP III, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-10 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-14 |
4 | 2023-02-06 |
4 | 2023-02-01 |
4 | 2023-01-31 |
4 | 2023-01-26 |
4 | 2023-01-24 |
View TRV GP III, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.